In mice, the Ter mutation causes primordial germ cell (PGC) loss in all genetic backgrounds 1 . Ter is also a potent modifier of spontaneous testicular germ cell tumour (TGCT) susceptibility in the 129 family of inbred strains, and markedly increases TGCT incidence in 129-Ter/Ter males [2] [3] [4] . In 129-Ter/Ter mice, some of the remaining PGCs transform into undifferentiated pluripotent embryonal carcinoma cells [2] [3] [4] [5] [6] , and after birth differentiate into various cells and tissues that compose TGCTs. Here, we report the positional cloning of Ter, revealing a point mutation that introduces a termination codon in the mouse orthologue (Dnd1) of the zebrafish dead end (dnd) gene. PGC deficiency is corrected both with bacterial artificial chromosomes that contain Dnd1 and with a Dnd1-encoding transgene. Dnd1 is expressed in fetal gonads during the critical period when TGCTs originate. DND1 has an RNA recognition motif and is most similar to the apobec complementation factor, a component of the cytidine to uridine RNA-editing complex. These results suggest that Ter may adversely affect essential aspects of RNA biology during PGC development. DND1 is the first protein known to have an RNA recognition motif directly implicated as a heritable cause of spontaneous tumorigenesis. TGCT development in the 129-Ter mouse strain models paediatric TGCT in humans. This work will have important implications for our understanding of the genetic control of TGCT pathogenesis and PGC biology.
Ter was mapped to mouse chromosome 18 near Fgf1 by following inheritance of genetic markers and two phenotypes: tumour incidence and PGC deficiency 7, 8 ( Fig. 1a-c) . Testis weight was used as a surrogate quantitative phenotype for Ter in high-resolution interspecific and intersubspecific backcrosses and intercrosses (Supplementary Fig. 1 ). A total of 2,753 meioses were examined from crosses between the B6.129-Ter congenic strain and A/J, C57BL/6J, C3H/HeJ and MOLF/Ei strains to avoid recombination 'hot'-and 'cold'-spots that may exist in the genome of particular strains. Genotyping of F 2 progeny with microsatellite markers narrowed the critical interval to 0.14 cM between 273 and 173RB (Fig. 2a) . Four overlapping bacterial artificial chromosomes (BACs) spanned the Ter locus: RG-MBAC_173P21, RG-MBAC_282N17, RG-MBAC_273D11 and RG-MBAC_284F9, derived from the 129 strain.
We used BAC complementation tests to reduce further the size of the critical interval. Transgenic mice were generated with each of the four overlapping BACs. They were crossed to B6.129-Ter congenic mice to eventually generate Ter/Ter mice carrying individual transgenes. Mice with BACs 282N17 and 284F9, but not BACs 273D11 and 173P21, rescued the germ-cell-deficient phenotype ( Supplementary  Fig. 1 ), fully or partially restoring fertility in Ter/Ter mice, as assessed histologically (Fig. 2c, d ) and by breeding performance (not shown), thus demonstrating that the overlapping region between 282N17 and 284F9 harbours Ter.
Four genes are present within the overlapping region of BACs 282N17 and 284F9 (Fig. 2b) . Comparison of the sequences of all the exons of these four genes from 129-Ter/Ter and 129-þ/þ mice revealed a single base change (C to T) in the coding region of the Dnd1 gene (Fig. 3a, b) , which is the orthologue of zebrafish dnd 9 . This substitution introduces a stop codon (R178X) in the coding regions of both isoforms of mouse Dnd1-encoded protein (DND1) at amino acids 178 and 190, respectively ( Fig. 3a ; accession numbers BC034897 and AY321066, NCBI). The mutation was found only in mice carrying Ter, but not in 129 substrains (129T2/SvEmsJ, 129S1/SvImJ, 129X1/SvJ) or other inbred strains (A/J, C57BL/6J, C3H/HeJ and MOLF/Ei). The base change introduces a new Dde1 restriction enzyme site within the Dnd1 sequence, enabling mice with the Ter allele to be distinguished from wild-type mice ( Supplementary Fig. 1 ).
To confirm that Ter is due to mutation in Dnd1, we used a 3.9-kilobase (kb) genomic DNA fragment derived from BAC 284F9 that encodes only the Dnd1 gene plus 860 base pairs (bp) and 510 bp flanking 5 0 and 3 0 ends, respectively, as a transgene (Tg(Dnd1)1Matn) to rescue the Ter/Ter phenotype. Ter/Ter males positive for Tg(Dnd1)1Matn showed partial rescue of the germ-celldeficient phenotype (Fig. 2e) . Although many seminiferous tubules remained germ-cell-deficient, some contained immature and mature sperm, which is unprecedented in Ter/Ter males. Double-stranded RNAs, which can result from expression of overlapping genes on opposite strands, can lead to loss of messenger RNA or translational silencing 10, 11 . Dnd1 and Wdr55 (2410080P20Rik) are encoded on opposite strands of DNA and overlap by 35 bp in the 3 0 ends of their last exon (Fig. 2b ). To test whether the mutation impairs function of Wdr55 and indirectly leads to the Ter phenotype, we created mice with targeted deletion of Wdr55 (wdr55 tm1Matn ) ( Supplementary Fig. 2 ). Mice homozygous for wdr55 tm1Matn are embryonic lethal and die before embryonic day (E)9.5. In contrast, Ter/Ter mice are viable but sterile. Moreover, double heterozygote males (þ wdr55 tm1Matn /Ter þ ) were not germcell-deficient and had gonad/body mass ratios ranging from 3.3 to 4.1, which is typical of wild-type but not Ter/Ter mice. Thus, Ter is not an allele of Wdr55. Therefore, functional complementation of Tg(Dnd1)1Matn transgenic mice together with normal testes in double heterozygotes demonstrates that the mutation in Dnd1 directly causes the Ter phenotype.
Expression of Dnd1 Ter was characterized by northern and western blotting analyses. Northern analysis revealed that transcripts of both Dnd1 isoforms are expressed in adult testes but only one isoform in adult heart (Fig. 3c) . Dnd1 transcripts were significantly decreased in tumours from 129-Ter/Ter males (Fig. 3d) . Transcript levels of the other genes in the critical interval (Wdr55, Ik and Ndufa2) were also reduced to varying extents in tumour tissue, suggesting that these genes also function in normal adult testes. The two DND1 protein isoforms differ at the first 33 and 45 amino acids of their respective amino terminus. A polyclonal antibody was generated against an 18-amino-acid peptide of one isoform of DND1 (indicated by A in Fig. 3a ). Western blotting of lysates from normal testes revealed a protein of 38 kDa, which is nearly the expected size (37.5 kDa) of the DND1 protein ( Supplementary Fig. 1 ). This antibody also recognized a 62.5-kDa glutathione S-transferase (GST)-DND1 fusion protein. DND1 was not detected in protein lysates from germ-cell-deficient testes of three different B6.129-Ter/Ter males or from tumours of four different 129-Ter/Ter males (Fig. 3e) . Thus, the various cell types of the tumours do not retain DND1 expression. However, a truncated DND1 protein was also not detected in Ter/Ter tumours. This rules out the possibility that tumour development is due to a dominant-negative-acting, oncogenic truncated DND1 protein. We note that the antibody we used detects only one isoform of DND1, and cannot rule out the possibility that the other isoform is still expressed. However, that seems to be unlikely because the mutation introduces a stop codon in both isoforms of DND1.
129-Ter/þ mice have a modestly elevated TGCT incidence, with 17% of the males having a unilateral tumour 2 . To test how Dnd1 is involved in tumour development in heterozygous males, we obtained testicular tumours and contralateral normal testes from two 129-Ter/þ mice, and bisected each of these tissues to examine Dnd1 protein and RNA expression. DND1 was not detected in tumour protein lysates (Fig. 3f) , although the contralateral normal testes of the 129-Ter/þ mice expressed DND1. To determine the mechanism of protein loss, we examined RNA from the 129-Ter/þ tumour samples. Because the tumour sizes were typically small, we used polymerase chain reaction with reverse transcription (RT-PCR) to amplify the full-length Dnd1 complementary DNA, and detected both the normal wild-type and mutated transcripts from tumour tissues via sequencing. We then developed an RT-PCRbased assay (see Methods) to distinguish visually mRNA from the normal (þ) and the Dnd1
Ter allele (Fig. 3g, left) . Using this method, the wild-type transcript was observed in tumours as well as in normal testes (Fig. 3g, right) . Because RT-PCR is a sensitive technique we were also able to amplify the Dnd1
Ter transcript (Fig. 3g , labelled m) from the Ter/þ RNA. However, the Dnd1
Ter transcript band is weaker compared with the wild-type allele. Taking into consideration both the western (Fig. 3f) and RT-PCR data (Fig. 3g, left) , it indicates that inactivation of DND1 expression from the wild-type allele of 129-Ter/þ (a second 'hit') has resulted in tumour development. In the case of the two samples examined, the second hit is probably a posttranscriptional mechanism such as translational silencing 12, 13 . The defect that underlies PGC deficiency and TGCT susceptibility in Ter males occurs during embryogenesis 1 . We therefore examined normal embryonic expression of Dnd1 and detected it at earlier stages than reported previously 9 . Whole-mount in situ hybridization using a Dnd1-specific RNA probe detected expression in the embryo and allantoic bud at E7.5, neuroectoderm at E8.5, and widespread expression in E9.5 embryo including the neural tube, head mesenchyme, first branchial arch and the hindgut, through which primordial germ cells are migrating (Supplementary Fig. 3 ). Dnd1 expression was also detected in the XY and XX genital ridges of E11.5 embryos (Fig. 4a, b) . Dnd1 expression was upregulated in the testis cords of the XY gonad between E12.5 and E14.5 (Figs 4c, e) , but downregulated between E12.5 and E14.5 in XX gonads (Fig. 4d, f) . Downregulation of Dnd1 in the XX gonad occurred progressively from anterior to posterior, similar to the wave of meiotic entry of XX germ cells 14, 15 . The contrasting patterns of Dnd1 expression in XX versus XY gonads may account for the differential susceptibility to teratocarcinogenesis in female versus male 129-Ter/Ter mice.
To visualize PGCs in 129-Ter/Ter embryos, we introduced a green fluorescent protein (GFP) transgene driven by the PGC-specific Oct4 promoter 16 (GOF-1/DPE/EGFP) in the 129-Ter strain. At E12.5, the number of GFP-labelled PGCs was significantly reduced in the urogenital ridges of 129-Ter/Ter compared with 129-þ/þ embryos ( Fig. 1d-f) . However, the few surviving PGCs in Ter/Ter embryos had successfully migrated to the genital ridges 1 , and tumours eventually occur in the testes of Ter/Ter mice. Therefore, Dnd1 is not essential for PGC migration in the mouse. Loss of PGCs in 129-Ter/Ter embryos precedes development of embryonal carcinoma cells and TGCTs. Inactivation of Dnd1 expression in PGCs during embryogenesis in 129-Ter/Ter mice is therefore implicated as the causal event that drives PGCs to exit the germ line and transform to embryonal carcinoma cells and TGCTs.
The mouse DND1 protein shares sequence similarity with proteins with RNA recognition motifs, with highest similarity to mouse apobec complementation factor (Acf, XP_129159; 34% overall amino acid identity and 48% identity in the RNA recognition motif) ( Supplementary Fig. 4) . Acf encodes the RNA-binding subunit of the RNA-editing enzyme complex (editosome) that converts specific cytidines to uridines in the apolipoprotein B transcript and other RNAs 17 . Several RNA-binding proteins are anomalously expressed in certain cancers [18] [19] [20] [21] [22] [23] , but it is unclear whether these are causes or consequences of tumorigenesis. DND1 may be an RNA-or DNA-binding subunit of other apobec-like proteins 24 involved in nucleic-acid editing, and the Ter mutation raises the possibility that TGCT susceptibility is a consequence of aberrant nucleic acid editing.
Various aspects of RNA biology have central roles in the development of the PGC lineage [25] [26] [27] . We show that functional inactivation of the mouse Dnd1 gene results in severe germ cell deficiency and increased TGCTsusceptibility. Our findings implicate a causal role of RNA biology in TGCT susceptibility, as DND1 has an RRM motif 28 and is most similar to Acf, which is involved in RNA editing. Extrapolating from the findings in Ter mice, although germ cell tumours present clinically in infants and young adults, it is apparent that genetic and environmental influences during embryogenesis increase the susceptibility of PGCs to tumorigenesis. 129-Ter mice are a valuable model system to study the initiating events of tumorigenesis, because the cell of origin of the tumours and the time of onset is defined, and now one of the defects (the Ter mutation in Dnd1) that predisposes to PGC transformation has been identified.
METHODS
Nomenclature. The orthologue of Ter in zebrafish is the dead end (dnd) gene 9 . On the basis of orthology with dnd, we call the mouse gene dead end, with gene and allele symbol Dnd1 and Dnd1
Ter , respectively. Mouse Dnd1 accession numbers are BC034897 and AY321066 (NCBI). The gene 2410080P20Rik (NM_026464) on the opposite strand and partially overlapping with Dnd1 was named Wdr55. Accession numbers for Ik and Ndufa2 are NM_011879 and NM_010885, respectively. Generation of genetic and physical maps. Polymorphic microsatellites were subcloned from the BACs using colony hybridization and mapped to chromosome 18 (primers to amplify the polymorphic markers are listed in Supplementary Fig. 4 ). Accession numbers of the BACs are: AC027276 for RG-MBAC_173P21, AC027278 for RG-MBAC_284F9, AC087795 for RP23-181H5 (which is the C57BL/6J equivalent of RG-MBAC_282N17) and AC087772 for RP23-326L17 (which is the C57BL/6J equivalent of RG-MBAC_2849F). BAC RG-MBAC_273D11 was not sequenced. Creation of BAC and Tg(Dnd1)1Am transgenics. BACs were purified, linearized and microinjected into FVB fertilized one-cell embryos 29 . PCR analysis to test for the presence of the BAC transgenes was carried out using the primers BAC-51-F 5 0 -CTTAACTATGCGGCATCAGAGC-3 0 and BAC-201-R 5 0 -GCCAGCTGGCGTAATAGCGAAG-3 0 , which amplified a 173-bp fragment from the vector-insert junction. Mice carrying the 129-derived chromosomal segment spanning D18Mit232, D18Mit94 and D18Mit17 (Ter/þ) and mice positive for BAC transgenes were intercrossed. Genotyping for the 129-derived chromosomal segment identified Ter/Ter mice bearing individual BAC transgenes. To generate Tg(Dnd1)1Matn, BAC 284F9 was digested with BglII and Nhe1 and subcloned into pBlueScript II KSþ. The 3.9-kb fragment encoding Dnd1 was identified by hybridization with 32 P-labelled PCR product of primers 4.13a-F and 4.13a-R (Supplementary Methods). The 3.9-kb fragment was purified, linearized and microinjected into FVB-fertilized one-cell embryos. Primers designed against the vector-insert boundary, A16.1-F 5 0 -GTCATCC TTGCACGCTGCGCACG-3 0 and A16.1-R 5 0 -GCTTGATATCGAATTCCTG-3 0 , were used for PCR genotyping for the presence of Tg(Dnd1)1Matn. Founder mice were crossed to the B6.129-Ter congenic strain. Mice carrying the 129-derived chromosomal segment spanning D18Mit232, D18Mit94 and D18Mit17 (Ter/þ) and positive for the Tg(Dnd1)1Matn transgene were intercrossed to generate Ter/Ter mice bearing the Tg(Dnd1)1Matn transgene. Testis weight measurements were taken for male progeny and stained sections were examined histologically. Gonad/body weight ratios and histology. Adult mice (4 weeks of age or older) were killed and the body weight and testis weight recorded. The gonad/body weight ratio was calculated as (gonad weight/body weight) £ 1,000. Testes or tumours were preserved in 10% phosphate-buffered formalin for at least 48 h. Sections (5 mm) were stained with haematoxylin and eosin. In situ hybridization. Embryos and gonads were fixed in 4% PFA for 12 h at 4 8C, washed in 0.1% Tween 20/PBS, dehydrated in 100% methanol and stored at 20 8C until used. Full-length cDNA of Dnd1 (image clone ID: 3470697) was used as probe. In situ hybridizations on mouse embryos were performed as described previously 30 . , in which Dnd1 is localized to testis cords (tc), whereas Dnd1 expression in an E12.5 XX (d) gonad (o) has a broad distribution throughout the gonad. e, f, Whole-mount in situ hybridization of an E14.5 XY (f) gonad, in which Dnd1 is localized to testis cords, in contrast to E14.5 XX (f) gonads, in which Dnd1 expression is reduced. g and h show section in situ hybridization of an E12.5 XY and E13.5 XY gonad, respectively. Dnd1 is specific to developing testicular cords in the E12.5 and E13.5 XY gonads. Scale bars represent 500 mm.
Generation of anti-DND1 antibody and GST-DND1. Rabbit polyclonal antibody was generated against the DND1 peptide spanning amino acids 16-33. GST-DND1 fusion protein was made by cloning Dnd1 cDNA in-frame into pGEX-2TK (Amersham Biosciences). GST-DND1 fusion protein was induced by isopropyl-b-D-thiogalactoside and affinity purified using glutathione Sepharose 4B. Assays to distinguish the Dnd alleles. To distinguish the mRNA transcripts from the wild-type and Ter alleles of Dnd1, total RNA from 129-þ/þ and 129-Ter/þ testes and tumours were treated with DNase1 before converting to cDNA using Superscript II Rnase H Reverse Transcriptase (Invitrogen). PCR was performed using the primers A25-F 5 0 -CGAGCTGACGGTGGACGGGCTGCC-3 0 and A25-R 5 0 -CTGCCTAGCTTCATCCGTTGAC-3 0 (primers 2, Fig. 3a ), which were designed to span exons 2 and 3 of Dnd1 to yield a 396-bp product. The RT-PCR products were digested with Dde1 before electrophoresis on a 7% acrylamide gel. Dde1 digestion of RT-PCR product produces fragments of 170, 103 and 97 bp from the wild-type allele and 139, 103, 97 and 31 bp from the Ter allele. The 31-bp fragment was not observed on the gel (Fig. 3g) . Controls to exclude amplification of contaminating DNA were performed on parallel RNA samples by leaving out Superscript II during the reverse transcription reaction (indicated in the lanes marked 2). The primers Dnd13-F (5 0 -CAGGAGCCAG AAAGGTATCAATA-3 0 ) and Dnd13-R (5 0 -CTTAACCCATTTAGGGTACCTGT-3 0 ) were used to amplify a 1,059-bp Dnd1 transcript by RT-PCR for sequencing.
